GRP
RETA

Global Retirement Partners’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Global Retirement Partners’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-6
Closed -$612 – 3363
2023
Q2 		$612 Hold
6
– – ﹤0.01% 2905
2023
Q1 		$612 Hold
6
– – ﹤0.01% 2877
2022
Q4 		$228 Hold
6
– – ﹤0.01% 2932
2022
Q3 		$0 Hold
6
– – ﹤0.01% 3064
2022
Q2 		$0 Hold
6
– – ﹤0.01% 2939
2022
Q1 		$0 Buy
+6
New +$178 ﹤0.01% 2830

Other funds holding RETA

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Global Retirement Partners's RETA Position: Q3 2023 in Review

Global Retirement Partners sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q3 2023, closing a stake of 6 shares — an estimated $612 sold.

Global Retirement Partners first reported a position in RETA in Q1 2022 and held it in 6 quarters. The position peaked at $612 in Q2 2023. 2 funds tracked by Wall St. Rank hold RETA as of Q3 2023.

  • Global Retirement Partners reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Global Retirement Partners sold 6 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q3 2023, an estimated $612.
  • Global Retirement Partners first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q1 2022 and held it in 6 quarters.
  • Global Retirement Partners's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $612 in Q2 2023.
  • 2 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q3 2023.

Based on Global Retirement Partners's 13F filing for Q3 2023, filed 13 Oct 2023.